S
Sarah E. Fowler
Researcher at George Washington University
Publications - 39
Citations - 28806
Sarah E. Fowler is an academic researcher from George Washington University. The author has contributed to research in topics: Diabetes mellitus & Metformin. The author has an hindex of 29, co-authored 36 publications receiving 27001 citations. Previous affiliations of Sarah E. Fowler include Henry Ford Hospital.
Papers
More filters
Journal ArticleDOI
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators.
Paul D. Stein,Pamela K. Woodard,John G. Weg,Thomas W. Wakefield,Victor F. Tapson,H. Dirk Sostman,H. Dirk Sostman,Thomas A. Sos,Deborah A. Quinn,Kenneth V. Leeper,Russell D. Hull,Charles A. Hales,Alexander Gottschalk,Lawrence R. Goodman,Sarah E. Fowler,John D. Buckley +15 more
TL;DR: In this article, the authors formulated comprehensive recommendations for the diagnostic approach to patients with suspected pulmonary embolism, based on randomized trials, and formulated diagnostic management recommendations were formulated based on results of the Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED II) and outcome studies.
Journal ArticleDOI
Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group
Ronald B. Goldberg,Marinella Temprosa,Steven M. Haffner,Trevor J. Orchard,Robert E. Ratner,Sarah E. Fowler,Kieren J. Mather,Santica Marcovina,Chris Saudek,Margaret J. Matulik,David E. Price +10 more
TL;DR: In this article, the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program was examined.
Journal ArticleDOI
HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: A randomized clinical trial
William C. Knowler,Sharon L. Edelstein,Ronald B. Goldberg,Ronald T. Ackermann,Jill P. Crandall,Jose C. Florez,Sarah E. Fowler,William H. Herman,Edward S. Horton,Steven E. Kahn,Kieren J. Mather,David M. Nathan +11 more
TL;DR: Baseline HbA1c predicted incident diabetes in all treatment groups and, in contrast to the superiority of the lifestyle intervention on glucose-defined diabetes, metformin and lifestyle interventions had similar effects in preventing Hb a1c- defined diabetes.
Journal ArticleDOI
Gadolinium-Enhanced Magnetic Resonance Angiography for Detection of Acute Pulmonary Embolism: An In-depth Review
Paul D. Stein,Pamela K. Woodard,Russell D. Hull,Fadi Kayali,John G. Weg,Ronald E. Olson,Sarah E. Fowler +6 more
TL;DR: G gadolinium-enhanced MRA may be a useful diagnostic alternative in some patients with suspected acute PE, particularly if they have an elevated creatinine level, have an allergy to radiographic contrast material, or should, if possible, avoid exposure to ionizing radiation.
Journal ArticleDOI
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)
Paul D. Stein,Alexander Gottschalk,H. Dirk Sostman,Thomas L. Chenevert,Sarah E. Fowler,Lawrence R. Goodman,Charles A. Hales,Russell D. Hull,Emanuel Kanal,Kenneth V. Leeper,David P. Nadich,Daniel J. Sak,Victor F. Tapson,Thomas W. Wakefield,John G. Weg,Pamela K. Woodard +15 more
TL;DR: The methods of the Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III) are described in detail and gadolinium-enhanced magnetic resonance angiography in combination with venous phase magnetic resonance venography is determined.